Judge Overturns $7.1M Jury Verdict Vs. Umbilical-Cord Blood Banks

Law360, New York (September 20, 2004, 12:00 AM EDT) -- A federal court in Delaware has overturned a $7.1 million jury verdict from October 2003 for patent infringement against several of the nation's largest umbilical-cord blood banks and granted the defendants a new trial.

The judge threw out a jury verdict that had stipulated a "reasonable royalty rate" of 6.125% and awarded PharmaStem Therapeutics Inc. $7.1 million from defendants ViaCell Inc., Cryo-Cell International Inc., CorCell Inc., and CBR Systems Inc.

Pharmacell sued the umbilical-cord blood banks in November 2002, alleging that that they infringed on patents...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.